Oligodendroglioma
Showing 1 - 25 of 44
AI R&D Tool in Adult Glioma and Other Primary Brain Tumours
Not yet recruiting
- Brain Tumor
- +4 more
- Resection
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 15, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)
Not yet recruiting
- Glioblastoma Multiforme
- +4 more
- SIACI of cetuximab and bevacizumab
-
Miami, FloridaJackson Memorial Hospital
Jul 14, 2023
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Adult Diffuse Glioma Based on Deep Learning
Recruiting
- Astrocytoma
- +2 more
- multi-parametric magnetic resonance imaging scan
- Pathology examination
-
Nanjing, Jiangsu, ChinaDepartment of Radiology, the Affiliated Drum Tower Hospital of N
Nov 21, 2022
High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)
Not yet recruiting
- High-grade Glioma
- +3 more
- Low-dose OKN-007, BID
- +3 more
- (no location specified)
Sep 26, 2022
Oligodendroglioma Trial in Germany (CETEG, PCV, RT)
Recruiting
- Oligodendroglioma
- CETEG
- +2 more
-
Heidelberg, Baden-Württemberg, Germany
- +18 more
Sep 22, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Astrocytoma, Glioblastoma, Oligodendroglioma Trial in Atlanta (Craniotomy, Quantitative Oblique Back-Illumination Microscopy)
Not yet recruiting
- Astrocytoma
- +2 more
- Craniotomy
- Quantitative Oblique Back-Illumination Microscopy
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2022
Oligodendroglioma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)
Recruiting
- Oligodendroglioma
- Tislelizumab plus Bevacizumab
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Aug 21, 2022
Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)
Not yet recruiting
- Glioma
- +3 more
- Retifanlimab
- All-trans retinoic acid
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 22, 2022
Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)
Recruiting
- Glioma
- +8 more
- MRI-guided laser ablation
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 22, 2022
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)
Recruiting
- Oligodendroglioma
- +2 more
- PCV chemotherapy
- Radiotherapy and PCV chemotherapy
-
Amiens, France
- +25 more
Jun 14, 2022
Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)
Recruiting
- Astrocytoma
- +11 more
- ProTRAIT
-
Maastricht, Limburg, Netherlands
- +2 more
Apr 12, 2022
CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)
Recruiting
- Central Nervous System Neoplasms
- +22 more
-
Bethesda, MarylandNational Institutes of Health
Mar 1, 2022
Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)
Recruiting
- Oligodendroglioma
- +2 more
- Radiation therapy
-
Oslo, NorwayOslo University Hospital
Jan 14, 2022
Qualitative, Qualitative, and Functional Studies Over First Year
Completed
- Astrocytoma
- +2 more
- Hepatitis A Vaccine
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Oct 28, 2021
Educating Brain Tumor Patients Using Patient-specific
Recruiting
- Brain Tumor
- +7 more
- Three-dimensional printed model
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Jul 10, 2021
MicroRNA-10b in Patients With Gliomas
Recruiting
- Astrocytoma
- +8 more
-
Boston, Massachusetts
- +3 more
May 30, 2021
Proteomic Characterization of Aggressive Oligodendrogliomas
Recruiting
- Oligodendroglioma
- Proteomic analysis
-
Bron, France
- +1 more
Apr 12, 2021
Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life
Withdrawn
- Anaplastic Oligodendroglioma
- +2 more
- Wear novoTTF-200A
- Quality-of-Life Assessment
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Dec 8, 2020
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo
Recruiting
- Cancer, All Types
- +44 more
-
Gainesville, GeorgiaSpecicare
Dec 2, 2020
Oligoastrocytoma, Astrocytoma, Oligodendroglioma Trial (device, procedure, other)
Completed
- Oligoastrocytoma
- +2 more
- fMRI
- +2 more
- (no location specified)
Sep 1, 2020
Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma Trial in Los Angeles (autologous dendritic cells pulsed with tumor
Withdrawn
- Giant Cell Glioblastoma
- +4 more
- autologous dendritic cells pulsed with tumor lysate antigen Vaccine
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020
Astrocytoma, Oligodendroglioma, Oligodendroastrocytoma Trial in Guangzhou (Radiotherapy, Temozolomide)
Recruiting
- Astrocytoma
- +2 more
- Radiotherapy
- Temozolomide
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 26, 2020